Form 8-K - Current report:
SEC Accession No. 0000353569-20-000009
Filing Date
2020-02-05
Accepted
2020-02-05 17:28:26
Documents
17
Period of Report
2020-02-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qdel2020equityincentiv.htm   iXBRL 8-K 54220
2 EXHIBIT 10.1 exhibit1012020cashicp.htm EX-10.1 9566
3 EXHIBIT 10.2 exhibit1022020equityin.htm EX-10.2 19342
4 EXHIBIT 10.3 exhibit103krollretirem.htm EX-10.3 47853
  Complete submission text file 0000353569-20-000009.txt   292960

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20200203.xsd EX-101.SCH 4660
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20200203_cal.xml EX-101.CAL 697
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20200203_def.xml EX-101.DEF 1547
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20200203_lab.xml EX-101.LAB 26142
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20200203_pre.xml EX-101.PRE 13653
12 EXTRACTED XBRL INSTANCE DOCUMENT qdel2020equityincentiv_htm.xml XML 4479
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 8585521100
QUIDEL CORP /DE/ (Filer) CIK: 0000353569 (see all company filings)

EIN.: 942573850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-10961 | Film No.: 20579873
SIC: 2835 In Vitro & In Vivo Diagnostic Substances